SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-97-004414
Filing Date
1997-11-12
Accepted
1997-11-12 00:00:00
Documents
4
Period of Report
1997-09-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. 10-Q 36656
2 STATEMENT RE: COMPUTATION OF LOSS PER SHARE EX-11 2084
3 IMPORTANT FACTORS RE. FORWARD LOOKING STATEMENTS EX-99 32472
4 FINANCIAL DATA SCHEDULE EX-27 2154
  Complete submission text file 0000950135-97-004414.txt   75054
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02138 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 97712614
SIC: 2836 Biological Products, (No Diagnostic Substances)